Erik Jakobsen
Overview
Explore the profile of Erik Jakobsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
2427
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gehr N, Timm S, Bennedsgaard K, Grosen K, Jakobsen E, Jensen A, et al.
Breast
. 2025 Feb;
80:104424.
PMID: 39978151
Chemotherapy-induced peripheral neuropathy (CIPN) is a concerning late effect of taxane treatment. This study aimed to explore and compare long-term symptoms and consequences of CIPN after docetaxel and paclitaxel treatment....
2.
Kaasgaard M, Bodtger U, Lokke A, Jakobsen E, Hilberg O
Front Rehabil Sci
. 2024 Dec;
5:1447767.
PMID: 39720625
Background: Surgical resection is the preferred treatment for localised non-small cell lung cancer (NSCLC). Rehabilitation is central in the management of the associated impaired quality of life, high symptom burden,...
3.
Ording A, Skjoth F, Ostergaard Poulsen L, Szejniuk W, Jakobsen E, Christensen T, et al.
JCO Oncol Pract
. 2024 Dec;
:OP2400526.
PMID: 39705615
Purpose: The concept of time toxicity of cancer treatment, defined as proportion of days from physical contact with the health care system, has been suggested as simple, patient-centered measure useful...
4.
Friis R, Pappot H, Hjollund N, McCulloch T, Holt M, Persson G, et al.
JCO Oncol Pract
. 2024 Dec;
:OP2400562.
PMID: 39657078
Purpose: Remote symptom monitoring of patients with cancer has previously shown potential for improving clinical outcomes. This study aimed to evaluate the effects of remote symptom monitoring in patients with...
5.
Rasmussen T, Gouliaev A, Jakobsen E, Hjorthaug K, Larsen L, Meldgaard P, et al.
BMC Cancer
. 2024 Nov;
24(1):1423.
PMID: 39558297
Introduction: This study aimed to evaluate the consistency of lung cancer case assessments across multidisciplinary team (MDT) sites in Denmark. The goal was to appraise the comparability of outcomes between...
6.
Steding-Jessen M, Engberg H, Jakobsen E, Rasmussen T, Moller H
Acta Oncol
. 2024 May;
63:339-342.
PMID: 38745484
Background And Purpose: There has been marked progress against lung cancer in Denmark. To gain further insight into the different aspects of the improvement, we examined the stage-specific incidence rates,...
7.
Ording A, Christensen T, Skjoth F, Noble S, Hojen A, Morkved A, et al.
Clin Lung Cancer
. 2024 May;
25(5):407-416.e1.
PMID: 38705834
Background: Venous thromboembolism (VTE) is a common complication in patients starting cancer therapies for non-small-cell lung cancer (NSCLC). We examined the risk and timing of VTE in patients with stage...
8.
Christensen T, Ording A, Skjoth F, Morkved A, Jakobsen E, Meldgaard P, et al.
Interdiscip Cardiovasc Thorac Surg
. 2024 May;
38(5).
PMID: 38702829
Objectives: Venous thromboembolic event (VTE) is a severe complication in patients with lung cancer undergoing thoracic surgery. Nevertheless, because of insufficient evidence, there are no clear guidelines, and VTE prophylaxis...
9.
Gouliaev A, Ali F, Jakobsen E, Dalton S, Hilberg O, Rasmussen T, et al.
Lung Cancer
. 2024 Mar;
190:107527.
PMID: 38432026
Background: This study evaluates the validity of the information in the Danish Lung Cancer Registry (DLCR). Since 2000, the DLCR has been a tool for monitoring interventions and outcome of...
10.
Levinsen A, Dalton S, Thygesen L, Jakobsen E, Gogenur I, Borre M, et al.
Int J Epidemiol
. 2024 Jan;
53(1).
PMID: 38205845
No abstract available.